1 - 20 of 145 Results

Managing My Ovarian Cancer Risk

Basser Young Leadership Council member Katrina Wells, a BRCA mutation carrier, shares her personal story with how she is managing her ovarian cancer risk.

BRCA and Pancreatic Cancer: Recent Advancements

Kim Reiss Binder, MD, a medical oncologist and clinical researcher with the Basser Center and the University of Pennsylvania, explains ongoing trials and recent advancements related to BRCA-related pancreatic cancer.

Changes in Classification of BRCA1/2 Mutations are Extremely Rare

In light of a recent news article, the Basser Center stresses that it is extremely rare that genetic testing reports change an interpretation from harmful to anything less than that. If you have been told that you have a BRCA mutation, it is exceedingly unlikely that anything has changed.

Ask Dr. Domchek: Enhancing PARP Inhibitors

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.